857P - Baseline fracture risk in men with prostate cancer starting the STAMPEDE trial

Brown, J.E. orcid.org/0000-0003-4960-3032, Handforth, C., Walsh, J. orcid.org/0000-0002-7122-2650 et al. (5 more authors) (2019) 857P - Baseline fracture risk in men with prostate cancer starting the STAMPEDE trial. In: Annals of Oncology. 44th ESMO Congress (ESMO 2019), 27 Sep - 01 Oct 2019, Barcelona, Spain. Elsevier BV , v334-v335.

Metadata

Authors/Creators:
Copyright, Publisher and Additional Information: © 2019 European Society for Medical Oncology. Published by Elsevier Ltd.
Keywords: Aging; Urologic Diseases; Osteoporosis; Cancer; Prostate Cancer; 6.1 Pharmaceuticals; 6 Evaluation of treatments and therapeutic interventions; Musculoskeletal; Cancer; 3 Good Health and Well Being
Dates:
  • Published (online): 8 January 2020
  • Published: October 2019
Institution: The University of Sheffield
Academic Units: The University of Sheffield > Faculty of Medicine, Dentistry and Health (Sheffield) > The Medical School (Sheffield) > Division of Genomic Medicine (Sheffield) > Department of Oncology and Metabolism (Sheffield)
Depositing User: Symplectic Sheffield
Date Deposited: 19 Jan 2023 15:35
Last Modified: 19 Jan 2023 15:35
Status: Published
Publisher: Elsevier BV
Refereed: Yes
Identification Number: https://doi.org/10.1093/annonc/mdz248.014
Related URLs:

Export

Statistics